NorthStar Medical Radioisotopes and YAP Therapeutics just moved. Here's exactly what to do next.
Who to reach, what to say, and why now — on NorthStar Medical Radioisotopes and YAP Therapeutics, plus every contract, funding round, and exec hire that follows. Verified, ICP-ranked contacts on demand (email + mobile).
Used by professionals at BlackRock, Oracle, Kleiner Perkins, HubSpot, and other leading firms — built on 10 years of proprietary signal data.
NorthStar Medical Radioisotopes and YAP Therapeutics Enter Into Collaboration Agreement for Radiopharmaceutical Product Development
Contract Type
agreement
Description
NorthStar Medical Radioisotopes, LLC and YAP Therapeutics, Inc. have entered into a collaboration agreement to develop and produce radiopharmaceuticals aimed at treating cancer and other chronic diseases. Within this collaboration, NorthStar will support the development of YAP Therapeutics' biologic products by supplying the radioisotope non-carrier added actinium-225 (n.c.a. Ac-225) and providing access to its radiopharmaceutical contract development and manufacturing (CDMO) services.